eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | c syndrome |
| Comorbidity | C0007222|cardiovascular disease |
| Sentences | 66 |
| PubMedID- 24453423 | Importantly also, whereas consistent disparities in the associations of cardiovascular risk factors including crp concentrations, blood pressure, lipid levels, obesity and metabolic syndrome with cardiovascular disease in black compared to white african patients with ra were recently identified by us [27–29], ethnicity did not impact the il-6-endothelial activation relationship in the present investigation. |
| PubMedID- 21130454 | Given the frequent concordance of metabolic diseases including diabetes, obesity, and metabolic syndrome with cardiovascular diseases associated with hyperlipidemia, it is important to understand the potential metabolic risks and benefits of therapies with distinct statins. |
| PubMedID- 22205060 | The worldwide obesity epidemic has brought to the author's attention the cardiometabolic risk factors and cardiovascular disease associated with the metabolic syndrome. |
| PubMedID- 24624345 | Moreover, many epidemiological studies have suggested that hyperuricemia, which may be an independent risk factor for metabolic syndrome [4], is associated with kidney disease, cardiovascular disease [5], cerebrovascular disease [6], obesity, diabetes, hypertriglyceridemia, and hypertension. |
| PubMedID- 20004035 | Aims: to compare the cardiovascular disease (cvd) risk associated with the metabolic syndrome (mets) and dysglycemia, independent of each other during a median follow-up of 6.7 years. |
| PubMedID- 21679922 | Microalbuminuria accounts for the increased risk of cardiovascular disease in patients with metabolic syndrome. |
| PubMedID- 20488778 | In any case, the results of the present study suggest that the endocrine disruptor bpa should be evaluated as a possible risk factor for gestational diabetes, type 2 diabetes, and cardiovascular disease associated with metabolic syndrome. |
| PubMedID- 25247821 | These findings have important public health implications due to the known cardiovascular disease risk factors associated with metabolic syndrome. |
| PubMedID- 20300596 | Depression is an independent risk factor for cardiovascular diseases and is associated with metabolic syndrome (mets). |
| PubMedID- 21318102 | Increasing plasma apn or enhancing apn signal transduction may be an ideal strategy to prevent and treat the cardiovascular diseases associated with metabolic syndrome. |
| PubMedID- 25918936 | The molecular processes that occur in metabolic syndrome can lead to cardiovascular disease pathogenesis and involve risk factors such as oxidative stress and inflammation [2,5]. |
| PubMedID- 21654497 | In the univariate analysis, variables significantly associated with hypertension were age, waist circumference, established cardiovascular disease, family history of hypertension, lipoatrophy, metabolic syndrome, duration of infection, cd4 nadir, hiv rna <50 copies/ml, and antiretroviral treatment. |
| PubMedID- 20349347 | The cardiovascular disease associated with the metabolic syndrome and with diabetes mellitus comprises vascular and myocardial abnormalities. |
| PubMedID- 19720470 | Insulin resistance (ir), which is a major component of metabolic syndrome (mets), is associated with cardiovascular disease risk. |
| PubMedID- 23873328 | Background and aims: metabolic syndrome (ms) leads to excess cardiovascular disease, including heart failure. |
| PubMedID- 22877354 | Data from a community based study was used to assess the risk for type 2 diabetes, cardiovascular disease and prevalence of metabolic syndrome in middle-aged men. |
| PubMedID- 26485682 | Sympathetic abnormalities play an important role in the pathophysiology of cardiovascular disease associated with metabolic syndrome, diabetes mellitus and obesity [1–4]. |
| PubMedID- 22682107 | Background: to evaluate the importance of oral glucose tolerance test (ogtt) in predicting diabetes and cardiovascular disease in patients with and without metabolic syndrome from a population treated in a primary care unit. |
| PubMedID- 25916279 | Conclusions: fetuin-a has a diagnostic potential as a biomarker for liver dysfunction, cardiovascular diseases and disorders associated with metabolic syndrome. |
| PubMedID- 21516134 | Although several studies have reported that the chemerin/chemr23 axis is strongly associated with cardiovascular disease and aspects of metabolic syndrome11, 26, 27, there was no direct evidence for the role of the chemerin/chemr23 axis in maintaining endothelial function. |
| PubMedID- 20609696 | In addition, hypertension is an important contributor to increasing cardiovascular disease risk in patients with the cardiometabolic syndrome. |
| PubMedID- 22417460 | High sensitivity c-reactive protein (hs-crp), a marker of systemic inflammation and a predictor of type 2 diabetes and cardiovascular disease, is associated with the metabolic syndrome and its separate components. |
| PubMedID- 24708775 | In clinical trials, bezafibrate has been highly effective at reducing cardiovascular disease risk in patients with metabolic syndrome or atherogenic dyslipidemia [32,37]. |
| PubMedID- 26089614 | Abdominal obesity (ao) and metabolic syndrome (mets) are associated with the cardiovascular disease and type 2 diabetes. |
| PubMedID- 20823276 | Aims: the adipokine visfatin, produced during obesity, has been reported to participate in the development of cardiovascular disease associated with metabolic syndrome. |
| PubMedID- 23334870 | This study assesses the feasibility and efficacy of a multifactorial approach for primary prevention of cardiovascular disease risk assessment in patients with metabolic syndrome in the daily clinical practice setting. |
| PubMedID- 22123633 | There seems to be an inverse relation between 25(oh)d serum concentrations and cardiovascular diseases, some components of the metabolic syndrome, and physical fitness. |
| PubMedID- 20940070 | Analysis results on population attributable risks showed that about a quarter of total diabetes occurrence and more than 10% of cardiovascular disease was attributable to the metabolic syndrome. |
| PubMedID- 22916265 | The higher risk of cardiovascular disease in patients with metabolic syndrome and hypertension could depend partly on the degree of sympathetic hyperactivity. |
| PubMedID- 24705461 | Aids-related lymphoma (arl), metabolic syndromes (including cardiovascular diseases, cvds; atherosclerosis and other lipid disorders), and hiv-associated dementia (had) – can be considered as all macrophage-mediated disorders in which nef is an unquestioned key factor [10]. |
| PubMedID- 21808142 | Cd36 deficiency is related to phenotypic expression of the metabolic syndrome, frequently associated with atherosclerotic cardiovascular diseases resulting in raised levels of glucose thereby contributing to type 2 diabetes (t2dm). |
| PubMedID- 24844874 | Background: subclinical cardiovascular disease is prevalent in patients with metabolic syndrome (metsyn). |
| PubMedID- 24008519 | Comment to: diversity of metabolic syndrome criteria in association with cardiovascular diseases--a family medicine-based investigation. |
| PubMedID- 23852333 | Diversity of metabolic syndrome criteria in association with cardiovascular diseases--a family medicine-based investigation. |
| PubMedID- 24278817 | We must consider that beyond the dyslipidemia, hypertension, atherosclerosis, and progression to type 2 diabetes, cerebral vascular disease, and cardiovascular disease, the consequences of cardiometabolic syndrome include type 3 diabetes, sleep apnea, malignancies, erectile dys-function, nonalcoholic fatty liver disease, end-stage renal disease, and osteoporosis. |
| PubMedID- 21785705 | Finally, there is some evidence that support an important role of mineralocorticoid receptor blockers in the treatment of resistant hypertension and in the prevention of cardiovascular diseases in patients with metabolic syndrome and type 2 diabetes mellitus. |
| PubMedID- 20509277 | Aim: to analyze the components of metabolic syndrome from patients with cardiovascular disease (myocardial infarction). |
| PubMedID- 24926685 | Nafld is a risk factor for cardiovascular diseases and is associated with metabolic syndrome. |
| PubMedID- 25857370 | Background and purpose: increased level of very low-density lipoprotein (vldl) is a key feature of the metabolic syndrome and is associated with cardiovascular diseases. |
| PubMedID- 24788056 | The most common conditions for which genetic counseling was provided were hypertrophic cardiomyopathy (hcm) (71% of participants), dilated cardiomyopathy (dcm) (61%), long qt syndrome (lqts) (56%), and genetic syndromes with cardiovascular disease (55%). |
| PubMedID- 24498934 | Relation between ev-markers and metabolic syndrome in patients with manifest cardiovascular disease. |
| PubMedID- 23961478 | For high-risk patients, ldl-c treatment goal was ldl <100 mg/dl but an ldl-c goal of <70 mg/dl was considered a therapeutic option for very high risk patients who had recent heart attacks, cardiovascular disease with diabetes, metabolic syndrome, or severe/poorly controlled risk factors. |
| PubMedID- 22121272 | Although metabolic syndrome leads to cardiovascular disease, psoriasis might be an independent risk factor for hypertension and cardiovascular disease even after correction for metabolic syndrome components. |
| PubMedID- 24393433 | Objective: metabolic syndrome (mets) is associated with cardiovascular disease (cvd). |
| PubMedID- 24445696 | Conclusion: in this small study, metabolic syndrome was found to be more frequently identified in turkish patients with psoriasis than in controls; metabolic syndrome could lead to increased cardiovascular disease risk in patients with moderate to severe psoriasis. |
| PubMedID- 21766575 | [the association of cardiovascular disease with metabolic syndrome and its risk factors in japanese urban cohort: the suita study]. |
| PubMedID- 21841320 | Objective: the aim of this study was to evaluate the effects of health checkup and the health education "hokenshido" program based on the concept that visceral fat accumulation causes metabolic syndrome (mets), leading to cardiovascular disease (cvd). |
| PubMedID- 25541285 | The insulin-like growth factor i system: physiological and pathophysiological implication in cardiovascular diseases associated with metabolic syndrome. |
| PubMedID- 24553695 | Dietary echium oil increases long-chain n-3 pufas, including docosapentaenoic acid, in blood fractions and alters biochemical markers for cardiovascular disease independently of age, sex, and metabolic syndrome. |
| PubMedID- 21466628 | Based on the increased cardiovascular disease risk of the metabolic syndrome, which is similar to stage 1 hypertension, both lifestyle modification and arb therapy are justifiable. |
Page: 1 2